Interleukin-1β inhibits synthesis of 5-lipooxygenase in lipopolysaccharide-stimulated equine whole blood.

This research examines how a pro-inflammatory cytokine, Interleukin-1β (IL-1β) influences the synthesis of two key substances involved in inflammatory processes in horses. It was found that IL-1β increases the production of anti-inflammatory prostaglandin E2 (PGE2) and decreases synthesis of pro-inflammatory 5-lipooxygenase (5-LO) products.

Research Methodology

• The main strategy of the research involved treating equine whole blood (EWB) with a compound known as lipopolysaccharide (LPS).
• The LPS treatment resulted in increased expression of IL-1β and suppressed expression of 5-LO. To quantify the changes, the researchers employed liquid-chromatography-mass spectrometry/multiple reaction monitoring (LC-MS/MRM).
• The researchers then combined IL-1β with calcium ionophore A23187 (CI), which correspondingly reduced synthesis of 5-LO products.
• Combinations of IL-1β with a COX-2 inhibitor (NS-398) or a Prostaglandin E Synthase inhibitor (CAY 10526) followed by calcium ionophore, led to a significant increase in 5-LO products.
• Furthermore, when equine blood was pre-treated with a phospholipase C inhibitor (U73122), and then exposed to LPS, the production of PGE2 decreased, but there was a subsequent increase in 5-LO products.

Key Findings

• The study found that the increase in PGE2 production directly led to a reduction in 5-LO products in LPS-treated EWB, and that this process was mediated by IL-1β.
• However, the study also highlighted that there may be other pathways and mediators involved in inhibiting 5-LO product synthesis, but these were not investigated in this study.
• Importantly, through reduction of 5-LO products, PGE2 is suggested to play an important role in regulating the initial onset and persistence of inflammatory responses within horses.

Research Implications

• The results of this study are significant in understanding the pathogenesis of inflammation in horses and potentially other animals or even humans.
• The research also indicates potential targets (like PGE2 and 5-LO) for therapeutic interventions aiming to control inflammation and its responses.